The microbiome, microbial-generated proinflammatory neurotoxins, and Alzheimer's disease

Journal of Sport and Health Science

Volumn 5, Issue 4, 2016, Pages 393-396

  Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FRAGILYSIN; LIPOPOLYSACCHARIDE; NEUROTOXIN;

ALZHEIMER DISEASE; BACTERIAL GROWTH; BACTEROIDES FRAGILIS; BLOOD BRAIN BARRIER; DIETARY FIBER; DYSBIOSIS; ENVIRONMENTAL FACTOR; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN; MICROBIOME; MOLECULAR EVOLUTION; NONHUMAN; NOTE; SIGNAL TRANSDUCTION; SYMBIOSIS;

EID: 85002194677     PISSN: 20952546     EISSN: 22132961     Source Type: Journal    
DOI: 10.1016/j.jshs.2016.08.008     Document Type: Note

References (26)

1. 1 Hamady, M., Knight, R., Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 19 (2009), 1141–1152.
2. 2 Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449 (2007), 804–810.
3. 3 Zhu, B., Wang, X., Li, L., Human gut microbiome: the second genome of human body. Protein Cell 1 (2010), 718–725.
4. 4 Jandhyala, S.M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., Nageshwar Reddy, D., Role of the normal gut microbiota. World J Gastroenterol 21 (2015), 8787–8803.
5. 5 Sankar, S.A., Lagier, J.C., Pontarotti, P., Raoult, D., Fournier, P.E., The human gut microbiome, a taxonomic conundrum. Syst Appl Microbiol 38 (2015), 276–286.
6. 6 Hugon, P., Dufour, J.C., Colson, P., Fournier, P.E., Sallah, K., Raoult, D., A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis 15 (2015), 1211–1219.
7. 7 Buxbaum, J.N., Linke, R.P., A molecular history of the amyloidoses. J Mol Biol 421 (2012), 142–159.
8. 8 Blanco, L.P., Evans, M.L., Smith, D.R., Badtke, M.P., Chapman, M.R., Diversity, biogenesis and function of microbial amyloids. Trends Microbiol 20 (2012), 66–73.
9. 9 Zhao, Y., Dua, P., Lukiw, W.J., Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's disease (AD). J Alzheimers Dis Parkinsonism, 5, 2015, 177, 10.4172/2161-0460.1000177.
10. 10 Hill, J.M., Lukiw, W.J., Microbial-generated amyloids and Alzheimer's disease (AD). Front Aging Neurosci, 7, 2015, 9, 10.3389/fnagi.2015.00009.
11. 11 Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome cell host microbe. Cell Host Microbe 17 (2015), 565–576.
12. 12 von Mikecz, A., Pathology and function of nuclear amyloid. Protein homeostasis matters. Nucleus 5 (2014), 311–317.
13. 13 Maldonado, R.F., Sá-Correia, I., Valvano, M.A., Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev 40 (2016), 480–493.
14. 14 Barczynska, R., Slizewska, K., Litwin, M., Szalecki, M., Kapusniak, J., Effects of dietary fiber preparations made from maize starch on the growth and activity of selected bacteria from the Firmicutes, Bacteroidetes, and Actinobacteria phyla in fecal samples from obese children. Acta Biochim Pol 63 (2016), 261–266.
15. 15 Choi, V.M., Herrou, J., Hecht, A.L., Teoh, W.P., Turner, J.R., Crosson, S., et al. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. Nat Med 22 (2016), 563–567.
16. 16 Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinction in gut microbiota compound over generations. Nature 529 (2016), 212–215.
17. 17 Sears, C.L., Geis, A.L., Housseau, F., Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest 124 (2014), 4166–4172.
18. 18 Vines, R.R., Perdue, S.S., Moncrief, J.S., Sentz, D.R., Barroso, L.A., Wright, R.L., et al. Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route. Vaccine 19 (2000), 655–660.
19. 19 Varatharaj, A., Galea, I., The blood-brain barrier in systemic inflammation. Brain Behav Immun, 2016, 10.1016/j.bbi.2016.03.010 Epub ahead of print.
20. 20 Lukiw, W.J., Bacteroidetes fragilis lipopolysaccharide (BF-LPS) and inflammatory signaling in Alzheimer's disease (AD). Front Microbiol, 7, 2016, 1544, 10.3389/fmicb.2016.01544.
21. 21 Javan, G.T., Finley, S.J., Abidin, Z., Mulle, J.G., The Thanatomicrobiome: a missing piece of the microbial puzzle of death. Front Microbiol, 7, 2016, 225, 10.3389/fmicb.2016.00225.
22. 22 Zhan, L.S., Davies, S.S., Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med, 8, 2016, 46, 10.1186/s13073-016-0296-x.
23. 23 Troletti, C.D., de Goede, P., Kamermans, A., de Vries, H.E., Molecular alterations of the blood-brain barrier under inflammatory conditions: the role of endothelial to mesenchymal transition. Biochim Biophys Acta 1862 (2016), 452–460.
24. 24 Greenlee, J.E., Brain abscess. Available at: http://www.merckmanuals.com/professional/neurologic-disorders/brain-infections/brain-abscess, 2016 accessed 15.08.2016.
25. 25 Clement, C., Hill, J.M., Dua, P., Culicchia, F., Lukiw, W.J., Analysis of RNA from Alzheimer's disease post-mortem brain tissues. Mol Neurobiol 53 (2016), 1322–1328.
26. 26 Zhao, Y., Jaber, V., Lukiw, W.J., Over-expressed pathogenic miRNAs in Alzheimer's disease and prion disease drive deficits in TREM2-mediated Aβ42 peptide clearance. Front Aging Neurosci, 8, 2016, 140, 10.3389/fnagi.2016.00140.